Detalhe da pesquisa
1.
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: History and scenario of patient blood management in the world and in Brazil.
Hematol Transfus Cell Ther
; 46 Suppl 1: S1-S4, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508946
2.
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Definition of Patient Blood Management.
Hematol Transfus Cell Ther
; 46 Suppl 1: S5-S7, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38523042
3.
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Implementation of Patient Blood Management (PBM).
Hematol Transfus Cell Ther
; 46 Suppl 1: S8-S11, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548507
4.
Targeting patient blood management's first pillar: A multicentric retrospective study on preoperative anemia.
Hematol Transfus Cell Ther
; 45(3): 338-341, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35882618
5.
Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability.
Oncotarget
; 14: 977-994, 2023 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085126
6.
COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality -cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM).
Hematol Transfus Cell Ther
; 2023 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37718131
7.
Development and implementation of a COVID-19 convalescent plasma program in a middle-income economy.
Hematol Transfus Cell Ther
; 44(2): 206-212, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35071990
8.
Lower access to risk stratification tests and drugs, and worse survival of chronic lymphocytic leukaemia patients treated in public as compared to private hospitals in Brazil: A retrospective analysis of the Brazilian registry of chronic lymphocytic leukaemia.
EJHaem
; 3(3): 698-706, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36051063
9.
Association of preoperative anemia and increased risk of blood transfusion and length of hospital stay in adults undergoing hip and knee arthroplasty: An observational study in a single tertiary center.
Health Sci Rep
; 4(4): e448, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34938895
10.
Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe.
Hematol Transfus Cell Ther
; 42(3): 200-205, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32405620
11.
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation.
Hematol Transfus Cell Ther
; 42(2): 103-110, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32313873
12.
Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation.
Hematol Transfus Cell Ther
; 42(2): 118-124, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537476
13.
BCL-2 as therapeutic target for hematological malignancies.
J Hematol Oncol
; 11(1): 65, 2018 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29747654
14.
Targeting patient blood management's first pillar: A multicentric retrospective study on preoperative anemia
Hematol., Transfus. Cell Ther. (Impr.)
; 45(3): 338-341, July-Sept. 2023. tab
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1514171
15.
Development and implementation of a COVID-19 convalescent plasma program in a middle-income economy
Hematol., Transfus. Cell Ther. (Impr.)
; 44(2): 206-212, Apr.-June 2022. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-1385048
16.
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.
Hematol Transfus Cell Ther
; 44(3): 410-418, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970751
17.
Evaluation of miR-15a, miR-16-1, ZAP-70, Ang-2, and Bcl-2 as potential prognostic biomarkers in chronic lymphocytic leukemia
Braz. J. Pharm. Sci. (Online)
; 58: e19332, 2022. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-1384002
18.
Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe
Hematol., Transfus. Cell Ther. (Impr.)
; 42(3): 200-205, July-Sept. 2020.
Artigo
em Inglês
| LILACS | ID: biblio-1134043
19.
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation
Hematol., Transfus. Cell Ther. (Impr.)
; 42(2): 103-110, Apr.-June 2020. ilus
Artigo
em Inglês
| LILACS | ID: biblio-1134022
20.
Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
Hematol., Transfus. Cell Ther. (Impr.)
; 42(2): 118-124, Apr.-June 2020. tab, ilus
Artigo
em Inglês
| LILACS | ID: biblio-1134012